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Abstract 
Recent evidence points to extra-telomeric roles of telomerase in regulating stem 
cell function. In this study, human embryonic stem cells (hESCs) were cultured in 
20% or 2% oxygen for up to 5 days and evaluated for telomerase reverse 
transcriptase (TERT) expression and telomerase activity. Results showed 
increased cell survival and maintenance of the undifferentiated state with 
elevated levels of nuclear TERT in 2% oxygen cultured hESCs despite no 
significant difference in telomerase activity. Pharmacological inhibition of TERT 
caused spontaneous differentiation while inhibition of the telomerase RNA 
component (TERC) did not. RT-PCR analysis revealed variations in transcript 
levels of full-length and alternate splice variants of TERT. Morpholino 
oligonucleotides that block specific pre-mRNA TERT splicing events induced 
spontaneous hESC differentiation. Together these results suggest that post-
transcriptional regulation of TERT under low oxygen could be a selective 
advantage for hESC survival and maintenance of the undifferentiated state by 
extra-telomeric telomerase isoforms.  
 
 
 
Key Words: human embryonic stem cells, microenvironment, telomerase 
reverse transcriptase (TERT), telomerase RNA component (TERC), Alternative 
splice variants of TERT. 
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1.1 Stem cells   
Stem cells can be defined as a subset of cells that have the capacity to 
self-renew and also give rise to several mature cell types through the process of 
cellular differentiation under the appropriate conditions (Uccelli et al., 2008).   As 
a direct result of these properties, there is a significant potential for the use of 
stem cells in regenerative medical applications.  Conditions such as Alzheimer’s, 
Parkinson’s, immune system deficiencies, anemia, and type I diabetes, are all 
candidate diseases suitable for stem cell aided therapy (Hendrix et al., 2007; Kim 
et al., 2009).  However, before this potential can be realized, a more complete 
understanding of stem cell biology is necessary.  As such, a vast body of 
research has been devoted to the study of stem cells and the processes that 
govern their phenotypic characteristics.   
Based on their ability to differentiate, stem cells can be specified into three 
broad groups: totipotent, pluripotent, and multipotent stem cells (Figure 1.1) 
(Mitalipov et al., 2009; Nakajima et al., 2011).  Totipotent stem cells retain the 
ability to differentiate into cells representative of all tissues present in an 
organism; including those are extra embryonic, such as the placenta.  Totipotent 
stem cells are typically only found in early preimplantation stage embryos prior to 
the formation of the blastocyst and implantation (Mitalipov et al., 2009).  
Pluripotent stem cells are derived from the cellular descendants of totipotent 
cells, and as such have a reduced capacity for differentiation.  Pluripotent stem 
cells can develop into any of the cell type representative of the three primaries  
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Figure 1.1.Human development and cell potency. Human development starts 
with the union of the male and female gametes (ovum and spermatozoon) at 
fertilization to form a zygote. This zygote undergoes many cellular (cleavage) 
divisions that eventually lead to exit of the developing embryo from the zona 
pellucida membrane and subsequent implantation into the uterine wall.  The 
blastomeres contained within the early embryo can be considered totipotent, 
retaining the potential to develop into the whole organism.  As embryo 
development progresses to the 8-cell stage and beyond, individual blastomeres 
gradually lose their totipotency, eventually resulting in pluripotent, multipotent, 
and terminally differentiated somatic cells. Figure adapted from Mitalipov et al., 
2009. 
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germ layers: endoderm, mesoderm or ectoderm.  However, pluripotent stem cells 
are unable to generate extra embryonic cell type such as the placenta. 
Multipotent stem cells are derived from pluripotent stem cells and as a result their 
capability to differentiate is more restricted (Borge et al., 2002). Multipotent stem 
cells can be found in various tissues of adult individuals as well as in the fetus 
and umbilical cord.  It has been suggested that an adult can contain up to 20 
different types of stem cells (Uccelli et al., 2008; Nakajima 2011).  These cells 
remain in a quiescent or non-dividing state for years until they are activated by 
disease or tissue injury to maintain and repair the tissue in which they are found 
(Uccelli et al., 2008). 
1.1.1 Embryonic Stem cells 
Stem cells can be further defined by their differentiation ability and tissue-
type of origin.  Embryonic stem cells (ESC) are defined as pluripotent cells 
derived from the inner-cell mass (ICM) of the pre-implantation blastocyst 
(Thomson et al., 1998).  The human blastocyst consists of approximately 70-100 
cells and forms at ~5 days post-fertilization.  A blastocyst is composed of an 
outer sphere of cells referred to as the trophectoderm from which the placenta 
will be formed, and an inner compact cell mass called the ICM which contributes 
to the formation of all the cells of the body (Figure 1.2).   
ESCs were first isolated from mouse (mESC) in 1981 from the ICM of 
embryos from inbred mice (Evans et al., 1981; Martin et al., 1981). mESCs were  
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Figure 1.2. Derivation of human embryonic stem cells. The human blastocyst 
forms at approximately 4 or 5 days after fertilization and contains from 64 to 
several hundred cells. It is comprised of an outer cell layer, the trophectoderm, 
and the inner cell mass (ICM). The ICM is harvested either by mechanical 
dissociation or by enzymatic digestion of the outer cells and subsequently plated 
on mitotically-arrested mouse embryonic fibroblast (MEF) feeder cells, then re-
plated to yield a population of embryonic stem cells. Once established, human 
embryonic stem cell lines can persist stably, apparently for years, in a 
proliferative state. 
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characterized by the ability to self-renew indefinitely in vitro when cultured on 
mitotically inactivated mouse embryonic fibroblast (MEF) feeder cell layers in the 
presence of leukemia inhibitory factor (LIF) (Williams et al., 1988;  Xu et al., 
2002).  The MEF cells were proposed to contribute to ESC derivation and 
maintenance through the provision of beneficial factors for the stem cell 
microenvironment (Thomson et al., 1998).  When cultures were supplemented 
with bone morphogenic protein 4 (BMP4) in addition to LIF, mESCs could be 
maintained indefinitely on a layer of gelatin, removing the requirement for MEFs 
(Williams et al., 1988; Xu et al., 2002).  In addition to these self-renewal 
capabilities, mESCs were also demonstrated to be pluripotent through a variety 
of assays, such as embryoid body (EB) development in vitro, teratoma formation, 
tetraploid complementation, and germ line transmission within in vivo mouse 
models.  The difference between these ESCs and the cells of the ICM is that the 
latter are a transient population within the developing embryo, while the former 
are stable in vitro artifacts of the derivation process.  Although ESC lines are 
typically derived through in vitro explants of the inner cell mass, recent reports 
have demonstrated alternative methods for their derivation, such as from single 
biopsied blastomeres (Klimanskaya et al., 2006; Geens et al., 2009). 
Human ESCs (hESC) were first generated through explant cultures of the 
ICM of embryos obtained from in vitro fertilization (Thomson et al., 1998).  For 
their derivation, the ICM of blastocyst stage embryos was cultured in the 
presence of serum and MEFs.  hESCs could be maintained indefinitely on these 
MEF layers in medium supplemented with basic fibroblast growth factor (bFGF).  
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In contrast to mESCs, hESCs cannot be maintained in an undifferentiated state 
in medium supplemented with LIF or BMP4, which has been shown to actually 
induce differentiation of these cells (Williams et al., 1988; Xu et al., 2002).  
However, in feeder-free conditions, hESCs can be maintained on an extracellular 
matrix layer called Matrigel™ in medium pre-conditioned by MEF layers, or in 
defined media supplemented with combinations of specific growth factors (Figure 
1.2).  hESCs are known to have strong expression  level for the nuclear cell 
markers Oct3/4 and Nanog (Andrews et al., 2005).  Additional differences 
between mESCs and hESCs have also been observed during propagation in 
vitro related to surface marker expression.  Undifferentiated mESCs are known to 
express stage specific embryonic antigen (SSEA1), whereas on hESCs this 
glycolipid antigen marks differentiated cells.  Opposite trends in SSEA3 and 
SSEA4 markers can also be observed, where mESCs (differentiated cells only) 
exhibit differential patterns of expression when compared with hESCs 
(undifferentiated cells only) (Xu et al., 2002).  
Ethical considerations abrogate the use of hESCs in in vivo assays such 
as tetraploid complementation or germ line transmission, and as such 
pluripotency of hESCs is commonly measured in vitro using embryoid body (EB) 
formation, and in vivo by transplantation into immune compromised mice to 
evaluate teratoma development.  Thus, the ability of hESCs to contribute to the 
development of an entire organism remains to be tested.  However, in light of 
this, the derivation of hESCs and their propagation in in vitro culture was a major 
breakthrough not only because of their perceived therapeutic potential, but also 
10 
 
for in vitro disease modeling and as a model system for investigating early 
developmental events (Thomson et al., 1998).   
1.1.2 Induced Pluripotent Stem cells 
The ethical considerations surrounding hESCs has prompted researchers 
to investigate alternative systems for study in this area.  Pluripotency in both 
mESCs and hESCs are characterized by the coordinated expression of the core 
transcription factors POU5F1 (Oct3/4), Nanog, and Sox2.  These three factors 
combine to regulate the expression of a large subset of genes related to 
maintenance of pluripotency as well as those important for the induction of 
differentiation.  It was recently observed that mouse fibroblasts could be 
reprogrammed to a cell state indicative of mESCs through retroviral mediated 
induction of Oct3/4, Sox2, c-Myc, and Klf4 (Takahashi et al., 2006).  These 
reprogrammed cells were referred to as induced pluripotent stem cells (iPSC) 
due to their similarities with their embryonic counterparts.  Shortly after the 
demonstration of mouse iPSCs, human fibroblasts were reprogrammed by using 
different combinations of Oct3/4, Nanog, Sox 2, c-Myc, Lin28, and Klf4 
(Takahashi et al., 2007; Park et al., 2008).   
Depending on the reprogramming process used, these stem cells will 
contain exogenous genetic material used to facilitate expression of the critical 
factors.  This genetic ‘footprint’ that remains due to genomic integration of the 
viral material is an undesirable side-effect of the reprogramming method (Leeb et 
al., 2008).  However, active research in the iPSC field has resulted in the 
11 
 
generation of ‘footprint-free’ stem cells that do not contain any exogenous 
genomic remnants.  Although these new methods have helped to overcome one 
major hurdle in iPSC research, there are still numerous concerns on the true 
equivalency between ESCs and iPSCs, as artifacts of the reprogramming 
process resulting from the cell type of which the stem cells are induced have 
been described in the literature. 
1.2 The Cellular Microenvironment 
 Outside of the core factors that have been found to be critical for the 
maintenance of pluripotency in ESCs, the environment directly surrounding the 
cells also plays an important role.  This extracellular milieu termed the stem cell 
‘microenvironment’ represents the immediate physical and chemical 
surroundings of a cell.  The stem cell microenvironment consists of numerous 
components, including: soluble factors, support cells, oxygen tension, 
morphogens, and the extracellular matrix.  The harmonized communication 
between these contributors helps to provide the biochemical and mechanical 
signals that enable stem cells to survive, proliferate, and differentiate (Li et al., 
2011).  Evidence of the effect of the microenvironment can be seen by the drastic 
changes observed through modulation of its components in stem cell culture.   
The soluble growth factors that are provided to ESCs in culture medium 
are critical for maintenance of a pluripotent state (Hynes et al., 2009).  An 
example of this is the multiple levels of TGF-β regulation, such as activation 
through Activin/Nodal signaling which is known to be one of the core pathways 
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critical for the maintenance of self-renewal and pluripotency of hESCs (Vallier et 
al., 2005).  The extracellular matrix provided by MEFs or Matrigel™ is also 
essential for preservation of the stem cell phenotype (Hakala et al., 2009; 
Hughes et al., 2010).  Further environmental effects can also be observed in 
other cell systems, where the ability of the microenvironment to reprogram 
human metastatic melanoma cells has been observed (Hendrixet al., 2007).  An 
example of this is the ability of the hESC microenvironment to reduce the 
clonegenicity and tumorigenesis potential of metastatic cells by down-regulating 
of Nodal expression (Postovit et al., 2008).  Additionally, chicken embryonic 
microenvironments have also been observed to have the potential to reprogram 
human metastatic melanoma cells to a neural crest cell-like phenotype (Hendrix 
et al., 2009).  Microenvironmental control can also be observed within the germ 
stem cell (GSC) niche (Zhao et al., 2008).  In the aging drosophila female, this 
stem cell niche undergoes age-dependent loss of GSC presence and activity that 
may be due to the deprivation of important signaling factors derived from the 
GSC niche (Pan et al., 2007).  
Other examples of microenvironmental effects can be seen in adult stem 
cell systems, such as in fate determination of mesenchymal stem cells (Tuan et 
al., 2002; Hwang et al., 2009). Fate and commitment of mesenchymal stem cells 
are regulated by their microenvironment factors, and the resultant effects can 
result in alterations in differentiation potential towards different tissues, such as 
cartilage and bones (Tuan et al., 2002).  However, due to the complexity these 
environments represent, it has thus far been challenging to characterize the 
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properties of the microenvironment in order to better understand the dynamic 
interaction with stem cells. 
1.2.1 The hESC Microenvironment 
Microenvironmental regulation starts in early embryogenesis in vivo 
resulting directly in control over the processes of cell proliferation and 
differentiation (Davey et al., 2006).  A similar relationship exists in vitro, where 
the characteristics of hESCs are influenced by a complex relationship that exists 
between the cells and their surrounding microenvironment (Figure 1.3).  In terms 
of soluble factors, hESCs are known to respond to a combination of different 
growth factors and morphogens.  While bFGF is thought to be essential for hESC 
maintenance, other factors belonging to the transforming growth factor-β (TGF-β) 
family, such as Activins, Nodal, BMPs, and growth determination factors (GDF) 
have all been observed to promote preservation or exit from the pluripotent state 
( Figure 1.3) (Stewart et al., 2008; Wu et al., 2009).  
Other families of soluble factors, such as the Wnt family, have also been 
observed to play critical roles in the regulation stem cell behavior in the 
microevironment (Sokol et al., 2011; Doble et al., 2007).  These pathways are 
also known to exhibit a significant amount of cross-talk between one another, 
resulting in a dynamic interplay of soluble factors within the stem cell 
microenvironment (Sokol et al., 2011). Interestingly, many of the core factors 
known to be effectors of the stem cell phenotype have been identified in  
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Figure 1.3. Multiple pathways converge to maintain hESC culture 
homeostasis. Maintenance of pluripotency of hESC is controlled by specific 
growth factors and signaling pathways.  Different molecules in the 
microenvironment affect both hESCs and differentiated cells (mouse embryonic 
fibroblasts (MEF) feeder cells). Figure adapted from Stewart et al., 2008 
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proteomic screens of medium conditioned by MEF layers, suggesting a potential 
reasoning behind their benefit in hESC culture. Aside from contributions as a 
result of factor secretion into the soluble portion of the microenvironment, support 
cells also facilitate attachment in a manner analogous to the extracellular matrix.  
The extracellular matrix also can play a direct role on the behavior of stem cells 
that is independent of the soluble environment.  It has been observed that some 
mechanical and physical factors such as matrix stiffness can affect self-renewal 
and differentiation of hESCs (Li et al., 2011).  As such, there has been a recent 
expansion in the development of patterned arrays of extracellular matrix 
components in an effort to facilitate elucidation of factors that regulate hESCs 
from this non-soluble portion of the microenvironment (Kobel et al., 2010). 
Moreover, proteomic studies have illustrated that matrices commonly used in 
hESC culture are rich in attachment and growth factor binding proteins, such as 
fibronectin (Hughes et al., 2011).    
Additionally, it has also been shown that hESCs can secrete morphogens, 
such as Left-right determination factors (Lefty) into the extracellular matrix that 
can promote a phenotypic change in metastatic melanoma cells (Hendrix et al., 
2007).  Proteomic analyses of these secreted matrices has since yielded a rich 
data set of potential factors that direct these changes and suggests interaction 
between the soluble and insoluble portions of the microenvironment (Hughes et 
al., 2011).  Taken together, these studies illustrate that the dynamic interplay of 
multiple soluble and insoluble factors cooperate to elicit tight control over hESC 
behavior in the microenvironment. 
17 
 
1.2.2 Oxygen Tensions in Microenvironment 
Outside of direct regulation of stem cells by support cells, the extracellular 
matrix, or soluble factors, direct control over stem cell fate has been observed to 
change with exposure to changing environmental variables such as oxygen.  
Oxygen availability is now known to be one of the most important elements of the 
microenvironment that has demonstrated roles in embryonic development and 
stem cell function (Simon et al., 2008).  The majority of focus regarding oxygen 
tension in stem cells has modeled changes as a result of exposure to hypoxia.   
Hypoxia can be defined as a state where the level of oxygen is decreased 
relative to the normal concentration of the dissolved gas, which is approximately 
2 – 9% for most mammalian cell types (Paran et al., 1998; Simon et al., 2008).  
Hypoxia has been shown to promote the maintenance of a primitive state in 
several stem cell and precursor cell populations (Simon et al., 2008).  A variety of 
different types of adult stem cells reside in a relatively hypoxic microenvironment 
when compared to other tissues of the body. For example, hematopoietic stem 
cells reside in a physically separated microenvironment from blood vessels 
where the oxygen tension is hypoxic (1 – 2%) (Harrison et al., 2002).  Neural 
stem cells also reside in hypoxic regions (3-4% oxygen) in the brain.  It has been 
observed that culture of neural stem cells in atmospheric oxygen conditions can 
cause mitotic arrest and increased differentiation, whereas culture in hypoxia 
revert these effects (Pistollato et al., 2007; Mohyeldin et al., 2010).  
Mesenchymal stem cells are also found within tissues that have low oxygen 
tensions, and although they are in close proximity to blood vessels their 
18 
 
microenvironment is still relatively hypoxic (Grayson et al.,  2007; Fehrer et al., 
2007).   
1.2.3 ESCs and Hypoxia 
Low oxygen microenvironments can generate specific niches for both the 
developing embryo, during embryogenesis, and in the adult that regulate cellular 
differentiation (Postovit et al., 2008; Dunwoodie et al., 2009).  Hypoxia or low 
oxygen tension microenvironments show improved in vitro embryo development 
of several species including human and mouse (Dumoulin et al., 1998; Orsi et al., 
2001). In the natural environment of hESCs, the human reproductive tract, the 
oxygen tension is low (~2%).  It has been observed that in in vitro hESC cultures, 
low atmospheric oxygen (~4% O2) supports self-renewal as well as decreasing 
the amount of spontaneous differentiation (Westfall et al., 2008; Mohyeldin et al., 
2010).  Although hypoxia can regulate the pluripotent state in several stem and 
precursor cell populations, the molecular mechanisms underlying these 
observations remains unclear. One major mode of oxygen-mediated factors is 
through hypoxia-inducible factors (HIFs) which play essential role in the cellular 
response to oxygen concentration (Patel et al., 2010).  Several studies have 
shown that HIF have a role in the maintenance of hESC pluripotency 
(Szablowska-Gadomska et al., 2011; Quail et al., 2011).     
Interestingly, Yu and colleagues established that low oxygen levels 
induced the in vivo gene expression of the catalytic subunit of the telomerase 
reverse transcriptase (TERT) in fish liver and testis (Yu et al., 2006).  In addition, 
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it has been observed that decreasing the oxygen level of the cell culture 
microenvironment augments replicative lifespan as well as decreasing the rate of 
telomere shortening through an increase in telomerase activity levels in fetal 
bovine fibroblasts (Betts et al., 2008).  Recent evidence indicates that hESCs 
express TERT and the telomerase RNA component (TERC) genes, resulting in 
high levels of telomerase activity.  However, following the induction of 
differentiation the amounts of TERT, TERC, and telomerase activity decrease 
(Yang et al., 2008). 
1.3 Telomerase 
 Due to the end replication problem of DNA polymerase, telomere 
shortening occurs at every cell division and limits the proliferative capacity of 
human cells to 50–70 cell doublings (Lechel et al., 2004). The enzyme TERT 
prevents ongoing telomere shortening by de novo synthesis of telomere repeats.  
TERT is a multi-subunit enzyme that adds telomeric sequence repeats 
(TTAGGG)n  to the 3' ends of all eukaryotic chromosomes.  TERT is a reverse 
transcriptase that utilizes an RNA molecule (TERC), a non-coding RNA 
(451 nucleotides long in humans), as a template to elongate telomeres 
(Smogorzewska et al., 2004).  
Telomerase activity is mostly found in cells with high-renewal capacity 
(stem cells, germline cells) and immortalized cells (cancerous cells) (Kim et al., 
1994; Aubert 2008).Telomerase activity is up-regulated in the large majority of 
human tumors compared with normal somatic tissues (Suárez et al., 2001).  The 
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high levels of telomerase activity are thought to provide chromosome stability, 
telomere length maintenance, and contribute to cellular immortality (Yang et al., 
2008).  Normal differentiated human cells lack telomerase activity due to the 
stringent transcriptional repression of the TERT gene, and during the oncogenic 
process, induction of TERT expression is required for telomerase reactivation 
(Lou et al., 2007). 
Mutations in TERT cause some disorders and diseases such as Cri du 
Chat Syndrome (CdCS), which is an autosomal deletion syndrome that results 
from loss of the distal portion of chromosome 5p, where the hTERT gene is 
localized (Zhang et al., 2003). Mice lacking telomerase activity show progressive 
telomere shortening in consecutive generations, with signs of premature aging 
(Lee et al., 1998) and hypertension (Perez-Rivero et al., 2006).  Interestingly, 
over-expression of TERT in transgenic mice promotes stem cell mobilization and 
proliferation in the absence of telomere length alterations (Flores et al., 2005), 
suggesting that TERT has non-telomeric functions. 
1.3.1 Alternative functions of telomerase 
 Recent research has revealed alternative functions for telomerase outside 
its primary role of synthesizing telomeric repeats.  Over expression of TERT can 
stimulate cell proliferation (Perrault et al., 2005), alter the cell state towards a 
progenitor stem cell-like condition (Lou et al., 2007), and activate stem cell 
division, migration, and self-renewal in hair follicle stem cells (Choi  et al.,  2008).  
Notably, telomerase appears capable of activating Wnt/β-catenin signaling by 
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mechanisms independent of telomeric DNA synthesis.  Full-length, constitutively 
spliced TERT can activate Wnt reporters, and the Wnt axis in vivo and in mESCs 
(Park et al., 2009).  This action is thought to act through the formation of a TERT 
complex that binds to the promoters of Wnt-target genes regulating their 
expression.  In addition, TERT has a proposed role in regulating oxidative 
damage-induced apoptosis in the mitochondria (Park et al., 2009).   
Ectopic expression of TERT and increased telomerase activity enhances 
the proliferation and colony-forming ability of hESCs but suppresses the in vitro 
differentiation capability to all primitive and embryonic lineages (Yang et al., 
2008).  Conversely, down-regulation of TERT by RNA interference causes 
reduced proliferation, loss of pluripotency and induced differentiation in hESCs 
(Yang et al., 2008).  These recent results indicate an important role for TERT in 
maintaining hESC pluripotency, cell cycle regulation, and differentiation capacity.  
However, these observations also suggest that TERT induces these effects by 
extra-telomeric, non-canonical mechanism(s).  Therefore it is critical to enhance 
our knowledge about this protein and its related functions. 
1.3.2 Alternative splicing system of hTERT transcripts 
 The human TERT gene contains 16 exons and 15 introns, spans ~40 kb, 
where exons 3-11 comprise the reverse transcriptase (Figure 1.4).  At least 10 
splice variants of hTERT have been recognized and their regulated expressions 
appear to contribute to the control of telomerase activity levels (Lou et al., 2007; 
Saeboe-Larssen et al., 2006).  Two major deletion variants are depicted in 
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relation to hTERT pre-mRNA structure (Figure 1.4). The dominant-negative α 
deletion spans 36 bp within exon 6 of the hTERT pre-mRNA.  This isoform is 
enzymatically inactive and appears to be a dominant inhibitor of telomerase 
activity when over-expressed (Figure 1.4) (Colgin et al., 2000).  The telomerase 
inactive β-deletion spans 182 bp, resulting in deletion of exons 7 and 8 in the 
hTERT pre-mRNA causing a truncated enzymatically inactive telomerase variant 
of hTERT.  Both deletions can combine into an hTERT α- β- deletion variant that 
inactivates telomerase activity (Colgin et al., 2000; Anderson et al., 2006). 
The splice variants of TERT are expressed in in a number of cancers and 
tumour cell lines as well as in early embryos during human development (Ulaner 
et al 2001).  These splice variants influence telomerase activity levels and cause 
variations in telomere length during differentiation (Brenner et al., 1999).  
Additionally, they display tissue-specific and gestational age dependent patterns 
of expression (Brenner et al., 1999).  Splice variants of TERT have also been 
observed to be differentially expressed in tumour cells under hypoxic conditions 
(Anderson et al., 2006).  However, conflicting studies have indicated that there is 
no correlation between the levels of alternative splice variants of TERT and the 
decrease of telomerase activity during differentiation (Liu et al., 2004; Majerska 
et al., 2011).  Collectively, these studies indicate the potential for alternative 
functional activities of TERT splice variants.  
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Figure 1.4. Genomic structures of hTERT and its alternative splicing. The 
human TERT gene contains 16 exons. Exons 3-11 consist of RT domain. The 
two major deletion sites are depicted in relation to hTERT mRNA structure. The 
dominant-negative α deletion spans 36 bp within exon 6, while β deletion spans 
182 bp resulting in deletion of exons 7 and 8 within the reverse transcription (RT) 
domain. Figure adapted from Anderson et al., 2006 
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1.4 Rationale    
 The proliferation and colony forming ability of hESCs is increased by the 
over-expression of full-length TERT (Yang et al., 2008). Conversely, the down-
regulation of all TERT transcripts by RNA interference causes reduced ESC 
proliferation and spontaneous differentiation (Yang et al., 2008).  Functional 
telomerase has been identified in the cytoplasm or in mitochondria of cells 
(Ahmed et al., 2008; Martinez et al., 2011).  However, the significance of its 
cytosolic function is presently unknown.  Recent reports propose TERT as a 
regulatory molecule that modulates transcription and implicates telomerase as a 
cofactor that acts in a progenitor cell context to facilitate a Wnt-regulated 
program of self-renewal, proliferation, or survival (Park et al., 2009). Many of 
these extra-telomeric roles of telomerase appear to not require its reverse 
transcriptase activity (Park et al., 2009; Chung et al., 2005).  
Alternate splice variants of TERT have been abundantly detected in early 
preimplantation stage embryos, various tissues during fetal development and in 
many cancer and tumour cell lines.   The observed non-canonical functions of 
TERT (Park et al., 2009; Ahmed et al., 2008; Martinez et al., 2011) necessitates 
further investigation of potential alternative roles for TERT splice variants beyond 
modulating telomerase activity levels (Liu et al., 2004; Majerska et al., 2011).   
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1.5 Hypothesis 
Alternate splice variants of TERT have extra-telomeric roles in the maintenance 
of hESC pluripotency and self-renewal. 
To address this hypothesis, three integrated aims of study are proposed: 
1. To determine the effects of hypoxia microenvironments on 
proliferation, pluripotency and levels/distribution of 
telomerase/TERT in human embryonic stem cells. 
2. To elucidate the effects of pharmacological inhibition of the 
telomerase TERT or TERC subunits on human embryonic stem 
cell state. 
3. To characterize hypoxia-induced regulation of TERT splice 
variant expression in human embryonic stem cells by modifying 
TERT splicing events using steric blocking antisense 
Morpholinos. 
 
Herein, we investigated the roles of TERT, TERC, and subsequent telomerase 
activity in hESCs.  To investigate microenvironmental contributions, we analyze 
TERT and telomerase expression and localization in hypoxic conditions.  
Additionally, we utilize small molecule and mediated inhibition of TERT and 
TERC to determine the individual roles of the individual components of 
telomerase activity.  Lastly, we employed blocking antisense morpholino 
oligonucleotides to characterize the contribution of individual TERT splice 
variants in maintaining the undifferentiated state.  Our findings show that extra-
telomeric TERT is one of the essential mechanisms/effectors through which 
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hypoxia modifies cell potential and proliferation of hESCs.  Additionally, we 
observe that post-transcriptional regulation of TERT has extra-telomeric means, 
which promote the self-renewal and pluripotency of hESCs through specific 
splice variants of TERT. 
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Chapter Two: 
 Materials & Methods 
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2.1 Human Embryonic Stem Cell Culture  
 H9 hESCs passage 25 (WiCell, Wisconsin) were cultured in six-well 
tissue culture plates on a monolayer of CF-1 irradiated mouse embryonic 
fibroblast (MEF) feeder layers (GlobalStem, Rockville, MD).  Irradiated MEFs 
were plated at a density of 250,000 cells per well of a 6-well gelatin coated 
culture dish.  Prior to plating of hESCs on MEFs, wells were rinsed with hESC 
medium composed of Knockout Dulbecco's modified eagle's medium 
(DMEM/F12), 20% Knockout serum replacement (KOSR), 1% non-essential 
amino acids, 2mM glutamine (CellGro, Manassas, VA), 0.1 mM 2-
mercaptoethanol (Fisher, Toronto, Canada), and 4 ng/mL of basic fibroblast 
growth factor (bFGF).  H9 hESCs were grown in hESC medium in all 
experiments where MEF feeder cells were utilized.  Cultures were incubated at 
37°C in 5% CO2 and the medium was changed daily.  hESCs were passaged 
mechanically using a glass pick every 5-7 days as required.  All media were 
passed through 0.22µm filters for sterilization prior to use.  All reagents were 
obtained from Life Technologies (Grand Island, NY) unless noted otherwise. 
2.2 Feeder-free hESC Culture  
For experimentation, hESCs were passaged to feeder-free conditions to 
limit transmission of MEF cellular material to analyzed samples.  For 
immunofluorescence, flow cytometry, RNA extraction, Telomerase Repeat 
Amplification Protocol (TRAP) assay, pharmacological inhibition of the catalytic 
component (TERT) and RNA component (TERC), and antisense Morpholino 
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Oligo (MO) deliveries experiments, H9 hESCs were cultured in feeder-free 
conditions.  For feeder-free growth, culture dishes were coated with a 1:30 
Matrigel™ (Growth Factor Reduced, BD Biosciences, Franklin Lake, NJ): DMEM 
mixture and placed at 37°C to promote gelation.  hESCs on Matrigel™ were 
cultured using hESC medium (as above) that had been pre-conditioned 
(according to previously established protocols (Xu,2001)) on MEF feeder layers 
(MEF-CM) and supplemented with a further 8 ng/mL of bFGF, or in commercially 
obtained mTeSR1 defined hESC medium (StemCell Technologies, Vancouver, 
Canada).  For normoxia (20% oxygen tension) and hypoxia (2% oxygen tension) 
experiments, H9 hESCs grown in feeder-free conditions were transferred to a 
37°C, 5% CO2 environment containing either 20% or 2% oxygen respectively.  All 
reagents were obtained from Life Technologies (Grand Island, NY) unless noted 
otherwise.   
2.3 RNA extraction and quantification 
H9 hESCs grown in feeder-free conditions in under normoxia (20% 
oxygen tension) and hypoxia (2% oxygen tension) were harvested from 6-well 
dishes for RNA extraction.  RNA was extracted using TriZOL® reagent (Life 
Technologies) according the manufacturer’s instructions. Briefly, an appropriate 
number of cells (approximately 106 cells) were reconstituted in 1 mL of TriZOL 
reagent and incubated for 10 minutes after vigorous shaking.  Chloroform (200 
µL, Fisher, Toronto, Canada) was then added to each tube and the mixture 
incubated for 10 minutes after vigorous shaking.  The tubes were then 
centrifuged for 15 minutes at 12,000 x g at room temperature.  The aqueous 
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phase was removed and transferred to a fresh tube containing an appropriate 
amount of isopropanol (500µl).  Tubes were shaken and then incubated for 10 
minutes, followed by centrifugation at 12,000 x g for 60 minutes at room 
temperature.  The resulting pellets were rinsed with 70% ethanol prior to 
reconstitution in nuclease free water (50µl).  RNA recovery was quantified using 
a NanoDrop 2000 Spectrophotometer (Thermo Scientific, Logan, UT). 
2.4 Real-time RT-PCR 
For reverse transcription reactions, the High Capacity Reverse 
Transcription Kit with RNase inhibitor (Life Technologies) was utilized. 1μg of 
RNA based on NanoDrop quantification was reverse transcribed to cDNA 
according to the manufacturer’s instructions.  The reaction was carried out in a 
BioRad Cl000 Thermal Cycler with the following cycle parameters: 25°C for 10 
minutes, 37°C for 2 hours, 85°C for five minutes, and 4°C hold.  For RT-PCR 
experiments that utilized TaqMan® gene expression assay pre-designed FAM 
labeled probes, the TaqMan® Universal PCR Master Mix was utilized (Life 
Technologies).  For all experiments where custom primers were used with 
SYBR® green detection, the Universal SYBR® Green Master Mix was used: 
primers are: TERT-2164S: (GCCTGAGCTGTACTTTGTCAA) and TERT-2620A: 
(CGCAAACAGCTTGTTCTCCATGTC) with an initial heating at 94°C for 90 s, 
followed by 35 cycles of 95°C for 25 s, 68°C for 50 s, and 72°C for 50 s. which 
targeted regions that contained the α and β splice sites.  The remainder of the 
primers and RT-PCR assay information can be found in Table 1.  For real-time 
RT-PCR, the samples were placed in a Cl000™ Thermal Cycler (BioRad, 
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Mississauga, Canada) and incubated at 50°C for 2 minutes followed by 10 
minutes at 95°C.  Samples were then amplified at 95°C for 15 seconds followed 
by 1 minute at 58°C for 46 cycles. 
  All samples were normalized to the large ribosomal protein RPLPO as an 
internal control, and fold changes calculated using the delta-delta-CT method. 
The following equation was used to calculate fold difference based on CT values 
(Pfaffl 2001):   
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Table 1.  Real Time PCR Primer Information. List of all primers used in real-
time PCR experiments. 
Target Assay ID NCBI Gene Reference 
alpha-fetoprotein   Hs00173490_m1 NM_001134.1 
GATA binding protein 4  Hs00171403_m1 NM_002052.3 
T, brachyury homolog (mouse)  Hs00610080_m1 NM_003181.2 
GATA binding protein 6  Hs00232018_m1 NM_005257.3 
paired box 6  Hs01088112_m1 NM_001127612.1 
neurogenic differentiation 1 Hs00159598_m1 NM_002500.2 
Pou class 5 homeobox 1 Hs00742896_s1 NM_203289.3 
Nanog homeobox  Hs02387400_g1 NM_024865.2 
caudal type homeobox 2 Hs01078080_m1 NM_001265.3 
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2.5 Immunofluorescence 
Culture dishes of H9 hESCs grown in feeder-free conditions in 20% or 2% 
oxygen were rinsed twice in PBS and incubated in fixing solution containing 4% 
paraformaldehyde in PBS for 15 minutes at room temperature.  For intracellular 
staining, fixed cells were rinsed and subsequently permeabilized with 0.1% Triton 
X-100 in PBS for 15 minutes.  Blocking of fixed cells was performed using Dako 
Serum Free Protein Block solution (Dako, Carpinteria, CA) according the 
manufacturer’s instructions.  Cells were then incubated with one of the primary 
antibodies against Oct-4 (Mouse anti-human/mouse monoclonal, 1:500 dilution of 
manufacturer stock, clone 10H11.2, Millipore, Billerica, MA), SSEA4 (mouse anti-
human monoclonal, 1:500 dilution of manufacturer stock, clone MC-813-70, 
Millipore), SSEA1 (mouse anti-human/mouse monoclonal, 1:500 dilution of 
manufacturer stock, clone MC-480, Millipore), or TERT (rabbit anti-human 
polycolonal, 1:100 dilution of manufacturer stock, Rockland, Gilbertsville, PA).  
Incubation time for all primary antibodies was 1 hour, in PBS containing 0.1% 
bovine serum albumin, at room temperature.  After rinsing, the cells were 
incubated with secondary antibodies specific for the chosen primaries.  
Secondary antibodies Alexa-fluor 488 goat anti-mouse IgG, Alexa-fluor 568 goat 
anti-mouse IgM (Life Technologies) and  goat anti-rabbit IgG fluorescein 
conjugate (Calbiochem, San Diego, CA) were all used at 1:2000 dilutions in PBS 
containing 0.1% bovine serum albumin, of manufacturer stocks.  Cells were 
incubated in secondary antibody solutions for two hours at room temperature and 
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then rinsed three times with PBS. Images obtained immediately while fixed cells 
remained in PBS. 
2.6 Flow Cytometry  
H9 hESCs grown in feeder-free conditions in 20% or 2% oxygen were 
harvested using Accutase® (Life Technologies) to obtain a single cell suspension.  
After centrifugation, hESC pellets were resuspended in 5% fetal bovine serum 
(FBS) in phosphate buffered saline (PBS).  Alexa-488 conjugated SSEA-4 
(EBiosciences, San Diego, CA) and Alexa-647 conjugated SSEA1 
(EBiosceinces), were added to the suspension based on approximate cell 
number according to the manufacturer’s instructions and incubated for one hour 
at 4°C.  After rinsing, cells were directly analyzed using an Accuri C6 flow 
cytometer (BD Biosciences). For TERT experiments, harvested cells were fixed 
in 4% paraformaldehyde in PBS for 10 minutes and subsequently permeabilized 
using 0.1% Triton X-100 in PBS.  After rinsing, cells were incubated in 
telomerase specific primary antibody (mouse anti-human monoclonal, clone 2C4, 
1:500 dilution of manufacturer stock, Abcam, Cambridge, MA).  Primary antibody 
incubations were carried out for 1 hour in 5% FBS in PBS at 4°C.  After rinsing, 
cells were incubated with an appropriate secondary (goat anti mouse polyclonal, 
Abcam, Cambridge, MA).  Representative negative control samples contained 
isotype controls for the primary antibodies used.  Secondary antibodies were 
incubated for 2 hours at 4°C.  After rinsing, cells were directly analyzed using an 
Accuri C6 flow cytometer (BD Biosciences).  Populations were gated according 
to forward and side scatter patterns with filtering for viable cells using 7-
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aminoactinomycin D stain added just prior to analysis.  Data were analyzed using 
FlowJo software (Tree Star, Ashland, OR). 
2.7 Real time quantitative telomeric repeat amplification protocol (RQ-
TRAP)  
Telomerase activity was measured by the fluorescent telomeric-repeat 
amplification protocol (TRAP assay) with the TRAPeze® RT Telomerase 
Detection kit (Chemicon International, Temecula, CA) according to the 
manufacturer’s instructions.  Briefly, cultured H9 hESCs, were lysed in CHAPS 
buffer for 30 minutes on ice and centrifuged at 12,000 x g for 20 minutes at 4°C.  
Protein concentrations were determined using the BCA protein assay (Pierce, 
Rockford, IL).  Telomerase activity was assayed using 2 μg of protein per 
reaction, and experiments performed in triplicate.  For all experiments, human 
embryonic kidney cells (HEK293T) were used as a positive control and human 
dermal fibroblast (hDF) as a negative control.  Telomerase, if present in the cell 
extract, will add telomeric repeat sequences (TTAGGG) sequences to the 3’ end 
of an oligonucleotide substrate.  The number of repeat sequences added by 
telomerase is quantified using real-time PCR by measuring the increase in 
SYBR® green fluorescence upon binding to DNA.  The parameters for real-time 
PCR were: 30 minutes at 30ºC, 2 minutes at 95ºC, followed by 45 cycles of 94ºC 
for 15 seconds, 59ºC for 60 seconds, and 45ºC for 10 seconds. 
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2.8 Antisense Morpholino Oligo (MO) blocking of TERT splicing events  
Antisense morpholino oligos (MO; Gene Tools, LLC, Philomath, OR) 
complementary to specific exon-intron or intron-exon boundaries of the pre-
mRNA sequence of TERT were used to specifically block the splicing of the α- 
(intron 5/exon 6) and β-splice (exon 8/intron 8) variants of TERT (Figure 2.1).  
Morpholinos that contained no specificity to any transcript were used as controls.  
These morpholinos were fluorescently tagged to allow convenient visualization 
using microscopy, permitting measurement of transfection efficiency.  hESCs 
were transfected by passaging them in the presence of the morpholino.  Briefly, 
hESC cells cultured on a MEF-feeder layer were picked up mechanically into 
mTeSR1 medium containing 20 µM of each morpholino (α-MO, β-MO) and then 
transferred to feeder-free conditions under 5% CO2 in air atmosphere.  hESCs 
were fed daily with mTeSRl that was contained 20 µM of each morpholino, for 
three days.  Treated hESCs were subsequently processed for RNA extraction 
and quantification, and assayed by real-time RT-PCR, immunofluorescence, and 
flow cytometry. 
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Figure 2.1 Morpholino oligonucleotides design for blocking α-, β-TERT 
splice variants. The morpholino oligonucleotide (MO) sequences designed from 
5’ to 3’, and complementary to  specific intron-exon or exon-intron boundaries of 
the pre-mRNA sequence of TERT, that blocks the alternate splice sites α- (intron 
5/exon 6) and β- (exon 8/intron 8) of TERT. 
 
 
 
 
 
 
 
 
 
39 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
2.9 Pharmacological inhibition of the catalytic component (TERT) and RNA 
component (TERC) of telomerase in hESCs  
Telomerase Inhibitor IX (Calbiochem) is a cell-permeable compound, 
containing m-phenylenediamide that inhibits the catalytic component (TERT) of 
telomerase (Seimiya 2002).  Telomerase Inhibitor III (Calbiochem) is a cell-
permeable hexameric phosphorothioate oligonucleotide (PS-ODN) compound 
that can recognize and bind to the telomerase RNA component (TERC) resulting 
in inhibition of telomerase activity (Pitts, 1998).  H9 hESCs were grown on six 
well plates in feeder-free conditions in the presence of either Telomerase 
Inhibitor IX (10µM, 20µM) or Telomerase Inhibitor III, (3µM, 5µM), in MEF-CM.  
hESCs were fed daily with MEF-CM that was supplemented with the 
corresponding inhibitor for three days.  Treated hESCs were subsequently 
assayed using immunofluorescence and flow cytometry. 
2.10 Statistics  
 For all experiments, statistical analyses were performed using Microsoft 
Excel 2010 or Graph Pad Prism software. Results are expressed as SD and 
three technical and biological replicates as indicated in figure legends. Statistical 
significance was determined using unpaired Students T-tests. Parametric data 
was analyzed by a one-way ANOVA followed by a post-hoc TUKEY’s test using 
Graph Pad Prism 5 software, while nonparametric data was analyzed by a one-
way ANOVA on ranks followed by a post-hoc Dunn’s test using Sigma Stat 3.5. 
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Statistically significant data was indicated if the P-value was 0.05 or less 
(p<0.05).  
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Chapter Three:  
Results 
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3.1 Hypoxia promotes cell viability and maintenance of the undifferentiated 
state in hESCs     
Proliferation and maintenance of the pluripotent state in hESCs is 
enhanced by culture in low oxygen conditions (Westfall et al., 2008).  During in 
vitro culture and expansion, hESCs have a tendency to spontaneously 
differentiate.  This phenomenon has previously been attributed to suboptimal 
culture conditions, including the use of atmospheric oxygen environments.  In 
contrast, hypoxic environments (2-5% oxygen tensions) prevent spontaneous 
differentiation and support self-renewal of hESCs (Ulaner et al., 1998).  Based on 
these findings, we utilized both high (20%) and low (2%) oxygen hESC 
microenvironments to correlate the abundance and localization of TERT, and 
resultant telomerase activity levels with hESC proliferation and maintenance of 
the undifferentiated state.           
Human ESCs were cultured in feeder-free conditions on Matrigel™ under 
conditions of normoxia (20% O2) and hypoxia (2% O2) for a total of 96 hours.  To 
control for culture variability resulting from colony starting size, cells treated in 
normoxic and hypoxic conditions were derived and split from the same 
population of hESCs.  To be consistence in the hESC attachment, they stayed in 
normoxia conditions for 24 hours after passage to attach in same conditions 
(Figure 3.1A), then they were moved to either a hypoxia or normoxia culture 
condition.  After total 96 hours, we observed hESCs in normoxia and hypoxia that 
displayed sharp edges and consisted of uniform colonies of compact cells  
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Figure 3.1 - Low oxygen promotes cell viability of hESCs. hESCs were 
grown in feeder-free conditions in hypoxia (2% O2) and normoxia (20% O2) for a 
total of 96 hours.  (A) Phase contrast microscopy images of H9 hESCs cultured 
in hypoxia and normoxia conditions.  Scale bars represent 200µm.  (B)  
Histogram depicting relative colony area measurements of hESCs in hypoxia and 
normoxia.  For each oxygen condition, 3 wells from 6-well plates were counted 
for 3 different experiments. Colonies were selected in each well by computer 
software and the average intensity graphed. Error bars represent SD, n=3, 
*p<0.05. (C) Flow cytometry analysis measuring viable cell counts between 
hESC cultures grown in hypoxia and normoxia. Viability was determined using 7-
AAD staining. Cell populations were gated based on 7-AAD exclusion (7-AAD 
exclude of nonviable cells in flow cytometric assays), graphs shows 7-AAD 
fluorescence in hypoxia, blue, relative to normoxia, red. (D) Mean fluorescence 
intensity plots derived from flow cytometry data representing number of alive 
cells by 7-ADD signal of hESCs grown in hypoxia and normoxia.  Error bars 
represent SD, n=3, *p<0.05.   
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(Figure 3.1A).  However, in normoxia we observed an increased number of 
colonies relative to hypoxia that contained regions of cells that had a flat and 
elongated morphology, consistent with cellular differentiation (Figure 3.1A).   
(Figure 3.1A).  From measurements of colony area we observed that hESC 
colonies in hypoxia were on average ~2X larger when compared to those in 
normoxia (Figure 3.1B).  To further investigate the apparent hESC growth rate 
differences under varying oxygen microenvironments, flow cytometry was 
performed to determine accurate viable cell counts.  We observed a decrease in 
the incidence of cell death, as indicated by 7-Aminoactinomycin D (7-AAD) 
staining, in hypoxia compared to normoxia (Figure 3.1C, D).  Taken together, 
these observations illustrate that hESCs grown in low oxygen have increased cell 
numbers when compared with those cultured in higher oxygen conditions.   
To examine the cellular changes related to pluripotency/differentiation 
status between hESC cultured in hypoxia and normoxia, hESCs were examined 
by immunofluorescence for the levels of pluripotency marker POU5F1 (herein 
referred to as Oct3/4), and for the cell surface differentiation marker, stage 
specific embryonic antigen 1 (SSEA1).  Oct3/4 is characteristic of 
undifferentiated hESCs, whereas SSEA1 is typically only found expressing in 
hESCs that have initiated differentiation (Lin et al., 2011). Cultures maintained in 
normoxic and hypoxic conditions both contained uniform distributions of Oct3/4 
fluorescence within hESC colonies (Figure 3.2A).  However, hESC colonies 
grown in normoxic cultures contained cells with visible amounts of SSEA1  
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Figure 3.2 - Hypoxia promotes maintenance of an undifferentiated state in 
hESCs. hESCs were grown in feeder free conditions in hypoxia (2%) and 
normoxia (20% O2) for a total of 96 hours.  (A) Immunocytochemistry detection of 
Oct3/4 and SSEA1 in hESCs cultured in 2% or 20% oxygen for 96 hours.  Scale 
bars represent 200µm.  (B, C)  Densitometric analysis of fluorescent intensities 
revealed the relative culture area occupied by Oct3/4 and SSEA1 expressing 
cells in hypoxic and normoxic cultures.  Scale bars represent SD, n=3. (D)  Flow 
cytometry data plots representing fluorescence signal for hESC populations 
harvested from normoxic and hypoxic cultures. Cells were assayed for Oct3/4 
and SSEA1.  (i, ii) Scatter plot with the gated cell population shown for 2% and 
20% oxygen. Populations were gated based on morphology and comparison to 
their matched isotope control and viability, according to forward scatter (FSC) 
and side scatter (SSC) pattern. (Forward Scatter measures cell size and Side 
Scatter measures complexity). Oct3/4(iii) and SSEA1(iv)  fluorescence in 2% 
(blue) and 20% (red) oxygen conditions relative to matched isotype controls 
(black).  Viability was determining using 7-AAD staining.  Mean fluorescence 
intensity plots derived from flow cytometry data representing Oct3/4 (E) and 
SSEA1 (F) signal intensities of hESCs grown in hypoxia and normoxia.  Error 
bars represent SD, n=3, *p<0.05. 
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fluorescence relative to hESCs cultured in hypoxia (Figure 3. 2A).  Densitometric 
examination of immunofluorescent signal intensities was performed to quantify 
the relative fluorescent pixel strength.  There was no significant difference 
between the relative areas occupied by Oct3/4 expressing cells between the two 
conditions (Figure 3.2 B).  However, cultures grown in normoxia (20% oxygen) 
contained significant (p<0.05) relative culture area occupied by hESCs 
expressing SSEA1 (Figure 3.2 C).  Flow cytometry analysis indicated that the 
number of SSEA1 expressing cells was increased in normoxic hESC cultures 
relative to hypoxic (Figure 3.2 D, F).  However, based on mean fluorescence 
intensity, flow cytometry data indicated a decrease in Oct3/4 fluorescence in 
normoxic hESC cultures relative to those in hypoxia (Figure 3.2 D, E).  Taken 
together, these data indicate that culture of hESCs in a relatively hypoxia (2% 
oxygen) microenvironment promotes maintenance of an Oct3/4-positive and 
SSEA1-negative undifferentiated cellular state.   
3.2 Hypoxia increases TERT levels and promotes it nuclear localization 
without significant changes in telomerase activity 
Based on our confirmatory findings, we utilized these high and low oxygen 
microenvironments to investigate the potential molecular mechanisms behind the 
maintenance of hESC self-renewal and pluripotency.  Previous studies have 
suggested that hESCs express TERT and have subsequently high levels of 
telomerase activity that are reduced upon their spontaneous differentiation (Yang 
et al., 2008). To investigate these observations further, we next sought to  
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Figure 3.3 - Hypoxia (2% oxygen) promotes the nuclear translocation of 
elevated TERT levels in hESCs, despite no significant difference in 
telomerase activity.  hESCs were grown in feeder-free conditions in relatively 
hypoxic and normoxic microenvironments to monitor TERT protein abundance 
and localization, as well as telomerase activity. (A) Immunofluorescence of TERT 
localization patterns and protein levels in hESCs cultured on Matrigel in 2% and 
20% oxygen.  Dashed circles denote single cells, and arrows point to areas of 
TERT protein abundance within cells.  (B) Flow cytometric analysis measuring 
TERT fluorescence levels in H9 hESCs cultured in 20% and 2% oxygen. (i, ii) 
Scatter plots with the gated cell population shown for 2% and 20% oxygen. 
Populations were gated based on morphology and comparison to their matched 
isotope control and viability, according to forward scatter (FSC) and side scatter 
(SSC) pattern. (Forward Scatter measures cell size and Side Scatter measures 
complexity). (iii) TERT fluorescence in 2% (blue) and 20% (red) oxygen 
conditions relative to matched isotype controls (black).  Viability was determining 
using 7-AAD staining.  (C) Mean fluorescence intensity plots derived from flow 
cytometry data representing TERT signal of hESCs grown in hypoxia and 
normoxia.  Error bars represent SD, n=3. (D) Relative telomerase activity in 
hESCs cultured in 2% or 20% oxygen. Error bars represent SD, n=3, three 
independent experiments performed. Different characters indicate significant 
differences (p<0.05).  
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determine whether the hESC growth and differentiation changes observed in 
hypoxia and normoxia correlated with telomerase activity levels, TERT protein 
abundance, and TERT localization in hESCs cultured under high and low 
oxygen.  Immunocytochemical analyses indicated that TERT protein was 
elevated and localized predominantly within the nuclei of hESCs when cultured in 
hypoxic conditions, but displayed a perinuclear/cytoplasmic localization pattern in 
cells grown in normoxia after both 4 and 6 days of culture (Figure 3.3A).  Flow 
cytometric analysis indicated a significant (p<0.05) increase in TERT levels in 
hESCs cultured in hypoxia when compared with those cultured in normoxia after 
5 days (Figure 3.3 B,C).  To evaluate whether the observed increase in TERT 
protein levels affected the amount of telomerase activity, the RQ-TRAP assay 
was performed on hESCs cultured in normoxia and hypoxia for 5 days.  
Interestingly, elevated TERT protein did not result in increased telomerase 
activity levels in hESCs, as there was no significant difference (p>0.05) between 
the measured quantities from the three populations examined (Figure 3.3 D). 
Overall, these findings indicate that low oxygen culture conditions promote the 
nuclear localization of elevated TERT levels in hESCs compared to those 
cultured in higher 20% oxygen without a significant alteration in the quantity of 
telomerase activity. 
3.3 Pharmacological inhibition of the catalytic TERT subunit of telomerase 
induces spontaneous hESC differentiation.  
Although recent evidence indicates that hESCs express TERT and TERC 
subunit genes, recent studies have shown that TERT overexpression in mouse  
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Figure 3.4 – Small molecule inhibition of TERT induces spontaneous hESC 
differentiation.  H9 hESCs were grown in feeder-free conditions in 20% and 2% 
oxygen following treatment with TERT inhibitor for 3 days. (A)  
Immunofluorescence detection of Oct3/4 and SSEA1in hESCs treated with 20µM 
of TERT inhibitor for 3 days in hypoxia.  Scale bars represent 200µm. (B) 
Relative telomerase activity levels of whole-cell lysates as measured by the Real-
time Quantitative TRAP (RQ-TRAP) assay.  Error bars represent SD, n=3. 
Different characters indicate significant differences (p<0.05). (C) Flow cytometry 
data plots representing fluorescence signal for hESCs treated with 20µM of 
TERT inhibitor (TI-IX), and non-treated cells in hypoxia (as control) for 3 days in 
2% oxygen. Cells were assayed for Oct3/4 and SSEA1. (ii,i) Scatter plots with 
the gated cell shown for both cell populations. Populations were gated based on 
morphology and comparison to their matched isotope control and viability, 
according to forward scatter (FSC) and side scatter (SSC) pattern. (Forward 
Scatter measures cell size and Side Scatter measures complexity). SSEA1(iii), 
and Oct3/4 (iv) fluorescence shown in 2% oxygen conditions (blue) and control 
(red) relative to matched isotype controls (black).  Viability was determining using 
7-AAD staining.  (D, E) Mean fluorescence intensity plots derived from flow 
cytometry data representing Oct3/4 and SSEA1 signal of hESCs treated with 
10µM and 20µM of TERT inhibitor for 3 days in 2% and 20% oxygen.  Error bars 
represent SD, n=3. Different characters indicate significant differences (p<0.05). 
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epidermis stem cells activates stem cell division, migration, and self-renewal that 
is independent of TERC (Choi et al., 2008 ; Yang et al., 2008).  To build on our 
previous data demonstrating that TERT protein abundance is significantly altered 
independent of telomerase activity in hypoxia relative to normoxia cultures, we 
investigated the potential roles for TERT and TERC in hESCs.  To undertake 
this, we utilized the small molecule inhibitors Telomerase Inhibitor IX (TI-IX, 
TERT inhibitor) and Telomerase Inhibitor III (TI-III, TERC inhibitor) that are 
specific for TERT and TERC, respectively (Seimiya et al., 2002; Pitts et al., 
1998).   
Based on pilot study and concentrations previously used on human cells 
that effective inhibited telomerase activity (Seimiya et al., 2002; Pitts et al., 1998), 
optimization of inhibitor concentrations in hESCs cultured in normoxia and 
hypoxia conditions indicated that TERT and TERC inhibitors were most effective 
at 20µM and 5µM, respectively (data not shown).     H9 hESCs were treated with 
20µM TERT inhibitor and analyzed by immunofluorescence to detect the levels of 
pluripotency marker Oct3/4 and differentiation marker SSEA1.  In normoxic and 
hypoxic cultures supplemented with TERT inhibitor, we observed noticeable 
fluorescence for SSEA1 coupled with a decrease in Oct3/4 levels, indicating that 
hESCs were spontaneously differentiating (Figure 3.4A).  These data were 
further validated through flow cytometry of normoxic and hypoxic hESC cultures 
in the presence of TERT inhibitor at concentrations of 10µM and 20µM.  A 
significant (p<0.05) decrease in Oct3/4 protein abundance was observed at both 
inhibitor concentrations in hypoxia, and at 20µM in normoxia (Figure 3. 4 C, D).  
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Additionally SSEA1 abundance was increased in the presence of 20µM of TERT 
inhibitor in both normoxia and hypoxia (Figure 3.4 C-E).   
Based on the observation that inhibition of TERT induced spontaneous 
hESC differentiation, we investigated whether these changes coincided with 
alterations in telomerase activity.  To evaluate the effect of the TERT inhibitor on 
telomerase activity in hESCs, the RQ-TRAP assay was performed on hESCs 
cultured in hypoxia and normoxia for 3 days.  We observed a decrease in 
telomerase activity in hESCs treated with 10µM of TERT inhibitor, and a 
significant (p<0.05) telomerase activity reduction in the presence of 20µM TERT 
inhibitor independent of oxygen condition tension (Figure 3.4B). As a whole, 
these data indicate that pharmacological inhibition of the TERT subunit of 
telomerase promotes a reduction in telomerase activity and results in 
spontaneous differentiation in hESCs cultured in both hypoxic and normoxic 
conditions. 
We next investigated what effect antagonism of TERC would have on 
hESCs cultured in normoxia and hypoxia conditions.  H9 hESCs were treated 
with 5µM of TERC inhibitor and analyzed by immunofluorescence to detect the 
levels of pluripotency marker SSEA4 and differentiation marker SSEA1.  In these 
experiments SSEA4 was utilized as opposed to Oct3/4 used previously for TERT 
inhibition.  After performing TERT inhibition experiments we noticed that there 
was a significant loss of cells due to the need of premeabilizing the fixed cells for 
antibody access since OCT3/4 is an intracellular marker. The use of the cell 
surface pluripotency marker SSEA4 on live cells limited this cell loss and gave  
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Figure 3.5 - Inhibition of the telomerase RNA component (TERC) does not 
cause spontaneous differentiation of hESCs.  H9 hESCs were grown in 
feeder-free conditions and treated with a small molecule inhibitor specific for the 
TERC subunit of telomerase.  (A) Immunofluorescence analysis of SSEA4 and 
SSEA1 levels in hESCs treated with 5µM of TERC inhibitor for 3 days in hypoxia.  
Scale bars represent 200µm.  (B) Relative telomerase activity levels of whole-cell 
lysates as measured by the Real-time quantitative TRAP (RQ-TRAP) assay.  
Error bars represent SD, n=3. Different characters indicate significant differences 
(p<0.05). (C) Flow cytometry data plots representing fluorescence signal for 
hESCs treated with 5µM of TERC inhibitor for 3 days in 2% oxygen. Cells were 
assayed for SSEA-4 and SSEA1 marker expression.  (i, ii) Scatter plot with the 
gated cell population shown for 2% oxygen and control. Populations were gated 
based on morphology and comparison to their matched isotope control and 
viability, according to forward scatter (FSC) and side scatter (SSC) pattern. 
(Forward Scatter measures cell size and Side Scatter measures complexity).  
SSEA1(iii)  and SSEA-4 (iv)  fluorescence in 2% oxygen (blue) and control (red) 
relative to isotype control (black).  Viability was determining using 7-AAD 
staining. Mean fluorescence intensity plots derived from flow cytometry data 
representing SSEA4(D) and SSEA1 (E) signal intensities, respectively, in hESCs 
treated with 3µM and 5µM of TERC inhibitor for 3 days in 2% and 20% oxygen 
Error bars represent SD, n=3. Different characters indicate significant differences 
(p<0.05). 
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more consistent results for pluripotency marker detection by immunofluorescence 
and flow cytometry.  Similar to Oct3/4, SSEA4 is a marker characteristic of 
undifferentiated hESCs (Yao et al., 2012).  In TERC inhibitor treated hESCs, we 
observed uniform SSEA4 fluorescence in normoxia and hypoxia cultured cells 
(Figure 3.5A).  Additionally, we observed no apparent fluorescent signal for 
SSEA1 in either culture condition (Figure 3.5A).  Similar to the results observed 
for immunofluorescence, when flow cytometry was performed on H9 hESCs 
treated with TERC inhibitor (3µM and 5µM), we observed no significant (p>0.05)  
changes in SSEA4 or SSEA1 abundance in hESCs treated and untreated with 
the TERC inhibitor (Figure 3.5 C,D).   
To validate the non-effect of TERC inhibition on hESC differentiation, we 
investigated whether inhibition of TERC promoted a change in telomerase 
activity.  The RQ-TRAP assay was performed on hESCs treated with 3µM and 
5µM of TERC inhibitor in hESCs cultured in normoxia and hypoxia conditions.  
After 3 days of culture a significant decrease in telomerase activity was observed 
in hESCs treated with 5µM of TERC inhibitor in both oxygen conditions (Figure 
3.5B).  Interestingly, the effect of TERT and TERC inhibition on telomerase 
activity was very similar (compare Figures 3.4B and 3.5B); however, inhibition of 
TERC did not promote spontaneous hESC differentiation.  Taken together, these 
findings indicate that although telomerase activity can be decreased by 
antagonism of both its catalytic (TERT) and RNA (TERC) components, this 
reduction cannot universally promote spontaneous hESC differentiation.    
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3.4 Normoxic and hypoxic culture conditions promotes differential 
expression profiles of telomerase isoforms that is indicative of distinct 
hESC states. 
Based on the results demonstrating that TERC inhibition does not promote 
spontaneous differentiation and that low oxygen conditions elevates TERT levels 
and promotes its localization to the nucleus without significantly changes in 
telomerase activity levels in hESCs, we next examined the transcript abundance 
of several alternate splice variants of TERT, many of which are known to have no 
telomerase activity (Park et al., 2009; Ulaner, G.A., et al., 2001; Anderson et al., 
2006).  These findings highlight the potential for hESC regulation based on 
expression of different TERT isoforms.  To determine whether the changes 
observed in our system operate in a splice variant dependent manner, we 
investigated patterns of TERT isoform expression in hESCs cultured in normoxia 
and hypoxia conditions.    
To determine TERT isoform transcript levels in hESCs cultured in 
normoxic and hypoxic conditions, we performed RT-PCR analysis using TERT 
isoform specific primers. Agarose gel electrophoresis of amplified samples 
revealed that constitutively spliced, full-length TERT, as well as the α- and β-
isoforms are expressed in H9 hESCs cultured in normoxia and hypoxia 
conditions (Figure 3.6 A, B).  However, both full-length TERT and the α-isoform 
transcript abundance are reduced significantly (p<0.05) in hESCs cultured 
hypoxic conditions compared to those in normoxia. (Figure 3. 6A, B). In addition, 
the dual deletion variant (α- β-isoform) showed no difference in transcript levels  
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Figure 3.6 - TERT splice variant expression profile changes in hESCs 
cultured in hypoxia compared to normoxia microenvironments.  hESCs 
were cultured in feeder-free conditions in either normoxia (20% oxygen) or 
hypoxia (2% oxygen) and harvested to monitor TERT isoform transcript 
abundance.  (A) A representative agarose gel electrophoresis of TERT splice 
deletion variant (α-, β-, a-β-) mRNA transcript levels in hESCs grown under low 
(2%) and high (20%) oxygen conditions for 5 days.  (B) Densitometric analysis of 
splice variant amplicons. Error bars represent SD, n=3. Different characters 
indicate significant differences (p<0.05). 
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between oxygen environments but were significantly (p<0.05) reduced compared 
to the other TERT splice variants.  Based on this differential expression pattern, 
we sought to determine isoform-specific roles for the TERT splice variants in 
hESCs in both oxygen conditions.   
 To reveal the potential biological roles for the TERT splice variants in 
hESCs, steric-blocking Morpholino antisense oligonucleotides were utilized 
(Postovit et al., 2008).  In this study, fluorescently tagged morpholino 
oligonucleotides (MO) were utilized to facilitate visualization in the cell MOs were 
designed with a sequence complementary to α- (intron 5/exon 6) and β- (exon 
8/intron 8) boundaries of the TERT pre-mRNA molecule (Figure 2.2).  
To facilitate cellular MO uptake, hESCs were passaged in the presence of 
the MO.  Using immunofluorescence, we observed that MO specific for α and β 
isoforms, as well as a scrambled control, were effectively taken up into hESCs 
(Figure 3. 7 A).  The efficiency of MO uptake was quantified using flow cytometry 
examining fluorescence of the control MO in a culture of H9 hESCs (97.8% 
efficiency) (Figure 3. 7B).  
To confirm the specificity and effectiveness of the TERT MOs, RT-PCR 
analysis was performed to measure constitutively spliced (full-length TERT) and 
alternatively spliced TERT isoform transcript levels.  cDNA derived from H9 
hESCs treated with either α- and β - MOs revealed a significant decrease in 
splice variant transcript levels in the presence of TERT splice variant MO 
compared to hESCs treated with the scrambled MO (Figure 3. 7C,D).  We also  
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Figure 3.7 - Steric-blocking morpholino antisense oligos alters TERT 
splicing events in hESCs.  hESCs were cultured in feeder-free conditions in 
normoxia (20%) or hypoxia (2%) conditions in the presence of 10µM of MO.  
hESCs were passaged in the presence of MO to facilitate uptake.  (A) 
Fluorescently labeled MO as observed by live cell fluorescence microscopy.  MO 
appears as green  fluorescence hESCs.  (B) Representative flow cytometry 
analysis of hESCs carrying scrambled control MO.  Percentage within the bar 
indicates the number of cells positive for MO fluorescence. (C) Agarose gel 
electrophoresis of PCR amplified cDNA samples shows a decrease in each 
TERT variant of TERT α- and β-isoform specific MO’s mRNA relative to control 
morpholino (C-MO) treated hESCs after treatment with 10µM MO for 72 hours.  
(D) Densitometry analysis of TERT splices variant expression in the presence of 
either MO.  Error bars represent SD, n=3. Different characters indicate significant 
differences (p<0.05). 
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observed a significant (p<0.05) decrease of full length TERT in α- MO treated H9 
cells but not in β-MO treated H9 cells (Figure 3. 7C,D). 
To determine the effect of isoform depletion on pluripotency marker 
expression, we assayed hESCs treated with MO for SSEA1 expression.  There 
was a significant increase in SSEA1 fluorescence in the presence of either α- 
and β-isoform specific MOs but not the scrambled MO (Figure 8A).  Based on the 
observation that a significant increase in SSEA1 fluorescence occurs in the 
presence of either α- and β-isoform specific MOs, we investigated whether these 
changes coincided with alterations in telomerase activity.  To evaluate the effect 
of the α- and β-isoform specific MOs on telomerase activity in hESCs, the RQ-
TRAP assay was performed on H9 hESCs treated with either α- and β – MOs.  
We observed a significant (p<0.05) telomerase activity reduction in the presence 
of both α- and β - MOs (Figure 3.8B). Taken together, these experiments 
revealed that morpholino antisense oligonucleoties can block specific pre-mRNA 
splicing of TERT and subsequently induce hESC differentiation based on SSEA1 
expression, and this can effect on telomerase activity reduction in β – MOs 
treated H9.  
Splice variants have been detected during development displaying tissue-
specific patterns influencing telomerase activity levels during differentiation 
(Brenner et al., 1999).  To further investigate TERT splice variant dependent 
regulation of hESC differentiation, MO treated hESCs were assayed for a panel 
of lineage specific markers using real-time quantitative RT-PCR (Figure 3. 8C).  
hESCs cultured in the absence of bFGF for 72 hours to induce spontaneous  
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Figure 3.8 – TERT morpholinos induce spontaneous hESC differentiation. 
hESCs grown in feeder-free conditions were assayed for TERT isoform 
expression after inhibition with TERT splice variant specific morpholino 
oligonucleotides (MO).  hESCs were passaged in the presence of MO to facilitate 
uptake.  Controls are hESCs grown in medium containing no bFGF to induce 
spontaneous differentiation (embryoid body (EB) medium).  (A) 
Immunofluorescence detection of SSEA1 (red fluorescence) in hESCs treated 
with scrambled control morpholino (C-MO) and TERT α- and β-isoform specific 
MO (green fluorescence in the overlay). Scale bars represent 200µm. (B) 
Relative telomerase activity levels of whole-cell lysates as measured by the Real-
time quantitative TRAP (RQ-TRAP) assay.  Error bars represent SD, n=3. 
Different characters indicate significant differences (p<0.05).  (C) Real-time RT-
PCR analysis of hESCs treated with 10μM of MO for 3 days. Graphs show real 
time RT-PCR analysis for various markers: undifferentiated hESCs (Oct3/4, 
Nanog), ectoderm (NeuroD1, PAX6), endoderm (GATA6, GATA4, alpha-
fetoprotein), mesoderm (T).  All samples were normalized to the large ribosomal 
protein (RPLPO) as an internal control, and fold changes calculated using the 
delta-delta-CT method.  Error bars represent SD, n=3. Different characters 
indicate significant differences (p<0.05).  
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differentiation were used as a control.  In the presence of both the α- and β-
isoform specific MO, there was a decrease in Oct3/4 and Nanog transcript levels 
(Figure 3.8C). Examining germ layer specific markers for ectoderm 
differentiation, we observed a significant (p<0.05) increase in the marker 
neurogenic differentiation factor 1 (NeuroD1) and paired box 6 (Pax6) (Figure 
8B).  However, there were no significant (p>0.05) changes in markers 
representative of endoderm and mesoderm lineages (Figure 3. 8C).  Taken 
together, these results indicate that MO inhibition of specific TERT isoforms can 
promote spontaneous hESC differentiation.  Additionally, the specific 
upregulation of the ectoderm specific marker NeuroD1 and Pax6 indicate that β-
isoform inhibition caused spontaneous hESC differentiation with a bias towards 
neuroectoderm. 
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The interactions between cells and their microenvironment are critical for 
the regulation of inter- and intra-cellular processes.  This is evident with hESCs, 
where subtle changes in the microenvironment can induce dramatic alterations in 
cellular phenotype.  In this study we set out to determine the dynamic interaction 
between hESCs and their microenvironment and the subsequent effects on 
extra-telomeric role(s) of telomerase in human embryonic stem cell potency and 
self-renewal.  Specifically, we investigated the effects of low oxygen on hESC 
self-renewal and pluripotency while we examined the resultant changes in 
telomerase reverse transcriptase (TERT) expression, localization, and activity.  In 
doing so, we have confirmed that a low oxygen microenvironment (hypoxia) 
promotes maintenance of an undifferentiated state in hESCs.  In addition, 
hypoxia prompts direct changes in telomerase subunit expression and its 
localization.  Perturbation of the telomerase through antagonism of the TERT 
(but not TERC) subunit, or specific splice variants of TERT, promotes 
spontaneous hESC differentiation.  Together, our findings suggest a direct link 
between hypoxia and regulation of the hESC phenotype through extra-telomeric 
mechanisms of TERT isoforms outside telomerase's typical role of telomere 
synthesis/maintenance.      
Many changes in protein expression have been observed in different 
oxygen tensions (Bertout et al., 2008). However knowing which proteins are 
expressed differently in varying oxygen tensions, and therefore which proteins 
may promote pluripotency is important for the development of methods to 
maintain hESC pluripotency and prevent their differentiation in culture. Hypoxia 
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has been shown to promote pluripotency in hESCs (Simon et al., 2008), but the 
mechanism by which this occurs in is not clear. Hypoxic environments have 
previously been observed to support different facets of hESC biology.  Recent 
works have demonstrated the beneficial effect of hypoxia towards generation of 
naïve hESCs that have characteristics of a true ground-state of pluripotency, 
rather than a more differentiation primed derivative (Kim et al., 2011).  
Additionally, hypoxia has been observed to promote the derivation of induced 
pluripotent stem cells (Yoshida et al., 2009).    
Our results demonstrate a reduced cell death coupled with an enhanced 
maintenance of an Oct3/4-positive, SSEA1-negative undifferentiated state of 
hESCs in hypoxia (2% oxygen) when compared to cells cultured in normoxia 
(20% oxygen) conditions.  This work supports previous studies that have 
demonstrated the beneficial effects of hypoxia on maintaining the undifferentiated 
state in hESCs (Westfall et al., 2008; Mohyeldin et al., 2010).  Similar to our 
findings, hypoxic environments (5% oxygen) have previously been observed to 
be beneficial for the maintenance of an undifferentiated hESCs state (Ezashi et 
al., 2005).  However, contrasting data for this finding have been presented, 
suggesting that hypoxia is not beneficial and dependent on the culture conditions 
employed (Chen et al., 2009).  These contrasting results can potentially be 
reconciled when one considers the differential growth and differentiation 
characteristics between individual hESC lines (Allegrucci et al., 2006).  These 
differences may also stem from the specific concentration of oxygen employed.  
In contrast to our study, previous research efforts have utilized 5% oxygen 
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environments.  It is likely that cell line characteristics and culture practices 
combine to result in phenotypic changes in hESCs in the face of changing 
oxygen tensions.     
As a natural byproduct of oxidative phosphorylation in aerobic cells, 
reactive oxygen species (ROS) are produced. The presence of ROS in a cell, 
places that cell under increased oxidative stress (Haendeler et al., 2003; Held et 
al., 2010).  Increased oxidative stress regulates TERT post-translationally by 
ROS-mediated phosphorylation of TERT which then exports TERT out of the 
nucleus into the cytoplasm through nuclear pores. As a result telomeres are 
shortened, cell may enter replicative senescence, and the antiapoptotic effects of 
TERT are decreased (Haendeler et al., 2003). In order to determine specific 
intracellular regulatory changes that result from alterations in environmental 
oxygen concentration, we analyzed TERT expression and localization along with 
subsequent telomerase activity in hESCs.  We observed an increased protein 
abundance as well as nuclear localization of TERT in hESCs cultured in hypoxia 
when compared to those in normoxia (Figure 3.3 A-C).  However, no significant 
difference in telomerase activity levels was apparent in hESCs cultured under 
low or high oxygen tensions (Figure 3.3 D).   
There are numerous oxygen sensitive genes and regulatory pathways that 
are well-known in hESCs (Westfall et al., 2008). One of these groups that have a 
potential link with telomerase activity is the hypoxia inducible factor (HIF) family 
(Westfall et al., 2008).  HIFs are known to play a fundamental role in the cellular 
response to oxygen concentration (Patel et aI., 2010).  Additionally, HIFs have 
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been shown to regulate self-renewal and pluripotency in hESCs cultured in low 
oxygen conditions (Forristal et al., 2009).  HIFs regulate the expression of over 
200 genes, including those associated with apoptosis and proliferation 
(Carruthers et aI., 2009).  Active HIF complexes exists as heterodimers 
comprised of an O2-regulated alpha subunit, and a constitutively expressed beta 
subunit (Majmundar et aI., 2010;  Prabhakar et aI., 2012).  HIF heterodimers 
regulate transcriptional responses by binding to hypoxia-response elements 
(HREs) on their target genes (Webb et aI., 2009; Prabhakar et aI., 2012).  
 Several studies have shown that HIFs have a role in the maintenance of 
hESC pluripotency (Szablowska-Gadomska et al., 2011; Quail et al., 2011). 
Interestingly, both telomerase (TERT, TERC) genes promoter sequences contain 
consensus HRE sites which under hypoxic conditions, expression of these genes 
has been shown to be up-regulated through the specific activities of HIF-1 
transcription factors (Nishi et al., 2004).  In addition recent evidence indicates 
hypoxia induces the transcriptional activity both hTR and hTERT gene promoters 
in a HIF dependent manner (Anderson et al., 2011).  These data suggest a 
potential link between hypoxia, HIF, telomerase activity, and TERT splice variant 
expression in some human cell types.  By extension, it is therefore possible that 
alteration of HIFs may affect TERT regulation or splice variant expression in 
hESCs, and explain the elevation of TERT protein expression regardless of 
telomerase activity change in hypoxia conditions (Figure 3.3).    
To further investigate the relationship between telomerase and hypoxia in 
the context of hESC self-renewal and differentiation, we utilized small molecule 
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inhibitors specific for the catalytic (TERT) and RNA (TERC) subunits of this 
enzyme. A previous study showed that knockdown TERT in human embryonic 
stem cells, induced their differentiation, reduced their proliferation, and caused 
them to loss pluripotency (Yang et al. 2008).  Conversely, over-expression of full-
length TERT in hESCs increases their proliferation and colony-forming ability and 
suppressed their in vitro differentiation capabilities, (Yang et al. 2008).  However, 
these modulations of TERT/telomerase levels were carried out in the presence of 
the telomerase RNA component (TERC).  Interestingly, evidence suggests that 
when TERC is knockdown, hTERT can interact with the RNA component of 
mitochondrial RNA processing endoribonuclease (RMRP) to form a distinct 
ribonucleoprotein complex that has RNA-dependent RNA polymerase (RdRP) 
activity that produces double-stranded RNAs that can be processed into small 
interfering (si)RNA (Maida et al., 2009).  
Our findings indicate that although telomerase activity can be decreased 
through inhibition of both the TERT and TERC subunits, this reduction cannot 
universally promote spontaneous hESC differentiation as measured by SSEA1 
expression (Figure 3.4, 3.5).  This is evidenced by the fact that inhibition of TERT 
prompted a rapid induction of hESC differentiation, whereas antagonism of 
TERC was unable to promote any cellular change in hESCs. Interestingly, these 
results were consistent between both normoxia and hypoxia.    
Although hESCs are known to express both TERT and TERC genes, our 
findings indicate that these two subunits may work independently of each other 
when they are uncoupled.  This highlights the potential for extra-telomeric roles 
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of TERT in hESCs.  In line with this hypothesis, recent data has shown that 
TERT can modulate signaling through the canonical Wnt pathway by acting as a 
transcriptional cofactor (Park et al., 2009; Greider 2012).  Maida et al. have also 
shown that knockdown of TERC increased TERT interaction with the RNA 
component of the mitochondrial RNA processing endoribonuclease (RMRP) that 
is involved in the production of siRNAs (Maida et al., 2009). There appears to be 
many extra-telomeric roles of telomerase that do not require its reverse 
transcriptase activity (Park et al., 2009; Chung et al., 2005).  TERT appears to be 
capable of activating Wnt/β-catenin signaling by mechanisms independent of 
telomeric DNA synthesis (Park et al., 2009; Martínez et al., 2011) (Figure 4.9).  
The Wnt family of proteins has known roles in a large number of cellular and 
developmental systems (Logan et al., 2004).  Signaling through the canonical 
Wnt pathway has also been observed to play critical roles in the regulation stem 
cell behavior in the microenvironment (Doble et al., 2007; Sokol et al., 2011). 
In addition, modulation of Wnt signaling has been shown to be critical for 
the proper maintenance of pluripotency and differentiation in mESCs (Nusse et 
al., 2008; Ten Berge et al., 2011).  Full-length, constitutively spliced TERT can 
activate Wnt reporters, the Wnt axis in vivo, and in mESCs (Park et al., 2009).  
These findings support a link between telomerase activity and stem cell 
pluripotency.  TERT potentially signals through the canonical Wnt pathway in an  
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Figure 4.9. Alternative functions of telomerase.  TERT has a role as a 
transcriptional modulator of the Wnt–β-catenin (β-cat) signaling pathway. Wnt 
activate the Wnt receptor at the plasma membrane of the cell then forms a 
complex and regulate the Wnt-target genes. In addition, in the mitochondria, 
TERT associates with the RNA component of mitochondrial and has role in 
regulating oxidative damage-induced apoptosis. There might be the potential link 
between the extra-telomeric function of TERT and Wnt/β-catenin signaling in 
modulating signaling pathways in stem cells.  Based on our findings, these 
pathways may operate by regulating endogenous expression of alternative TERT 
isoforms in hESCs. Figure adapted from et al., 2011. 
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extra-telomeric fashion independent of TERC, suggesting a potential explanation 
for the differential outcome observed from their pharmacological inhibition (Figure 
4.9). It would be interesting to examine these extra-telomeric effects of 
telomerase in hESCs and to determine whether they are mediated by alternate 
splice variants of TERT. 
Our results demonstrated that TERC inhibition does not promote 
spontaneous differentiation and that low oxygen conditions elevates TERT levels 
and promotes its localization to the nucleus without significantly changes in 
telomerase activity levels in hESCs. Interestingly, when we examined for the 
expression of specific alternate splice variants of TERT (that have partial 
deletions in the reverse transcriptase (RT) domain), we observed differential 
patterns of expression for the TERT isoforms between normoxia and hypoxia 
conditions (Figure 3.6).  Ezashi et al. have demonstrated that the 
microenvironment can regulate alternate splicing of the FGF receptors (Ezashi et 
al., 2011).  It also has been shown that telomerase/TERT modulates Wnt 
signaling without its telomeric ability (Park et al., 2009). So it is possible that 
alternate splice forms of TERT may be expressed in hESCs that don't contain 
reverse transcriptase (telomeric) function and may act in an extra-telomeric 
fashion to govern stem cell state (Figure 4.9).  
Steric blocking of both specific α- and β-splice isoforms of TERT using MO 
resulted in spontaneous hESC differentiation as indicated by increased SSEA1 
marker levels (Figures 3.7, 3.8).   However we observed a significant telomerase 
activity reduction only in the presence of β–MOs (Figure 3. 8B). Blocking of a 
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specific TERT splice sites also caused the increase and/or decrease of other 
TERT isoforms and had opposing effects on the amount of full-length TERT 
transcripts as well (Figure 3. 7C), which may cause different telomerase activity 
for α- and β–MOs.   In addition to the changes observed in relation to 
maintenance of an undifferentiated hESC state, when cultures were 
supplemented with isoform specific MOs, there was also marked differences in 
specific differentiated marker expression after the induction of spontaneous 
differentiation.  Enhanced expression of the marker NeuroD1 and Pax6 in the 
presence of β–MOs, and the absence of change in the other assayed factors 
suggest a biased differentiation towards the ectodermal lineage.  
Morpholino oligonucleotides (MO) have previously been leveraged to 
modify TERT splicing in human prostate carcinoma cells (Ahmed et al., 2008).  
Oligonucleotide exposure promoted a decrease in the full-length hTERT 
transcript with a concomitant increase in alternatively spliced transcripts (Ahmed 
et al., 2008).  The resultant effect was an inhibition of telomerase activity, 
reduction of cell growth, and induction of apoptosis that was independent of 
telomere-shortening (Ahmed et al., 2008). Our data are in agreement with those 
from small molecule inhibition of specific telomerase subunits, wherein 
antagonism of TERT promoted hESC differentiation in a mode independent of 
oxygen tensions.  These findings suggest that TERT can promote phenotypic 
changes in hESCs in a splice isoform-dependent manner.   
The generation and function of alternatively spliced TERT isoforms is 
potentially regulated through multiple pathways (Figure 4.9).  It has previously 
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been observed that telomerase activity through alternative TERT splicing can be 
mediated through the transforming growth factor β family pathway (Cerezo et al., 
2002).  Alternatively, many different transcription factors, including c-Myc, bind to 
the 330–base pair minimal TERT promoter and regulate transcription (Greider 
2012).  c-Myc has previously been implicated in the modulation of many cell 
functions, including cell cycle regulation, proliferation, growth, differentiation, and 
metabolism (Junttila et al,  2008).  It acts as a transcription factor for an 
extremely large number of genes – suggested to be as high as 15% of the genes 
in the genome (Fernandez et al, 2003).     
Full-length TERT directly modulates Wnt/β-catenin signaling by acting as 
a cofactor in a β-catenin transcriptional complex with BRG1 on gene promoters 
for c-Myc and Cyclin D1 in the mouse (Sarin et al., 2005;  Shkreli et al., 2012).  It 
has been shown this extra-telomeric role of full length TERT is conserved in a 
TERT mutant without reverse transcriptase (telomeric) function (Park et al., 
2009), supporting the possibility that alternative splice forms of TERT, many of 
which carry natural deletions in the RT domain, might also serve in similar extra-
telomeric roles to modulate gene transcription in stem cells.  This further 
highlights the potential link between the extra-telomeric function of TERT and 
Wnt/β-catenin signaling in modulating signaling pathways in stem cells (Figure 
4.9).  Based on our findings, these pathways may operate by regulating 
endogenous expression of alternative TERT isoforms in hESCs.       
The differential expression pattern of TERT isoforms dependent on 
oxygen concentration suggests transcriptional regulation dependent on 
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environmental conditions.  It has previously been shown that cells can use 
alternative splicing to rapidly and specifically alter gene expression, such as in 
response to an environmental stress (Pleiss et al., 2007).  The presence of 
alternate TERT splice variants indicates that these splicing events are not 
random and suggest an important physiological role. This altered splice variant 
pattern was accompanied with an increased cell survival (reduced cell death) and 
maintenance of the undifferentiated state along with nuclear translocation of 
TERT protein under hypoxic conditions (Figure 4.9). Many human genes are 
known to be alternatively-spliced in response to hypoxia, and in some cases this 
process has appear to be regulated by HIF1 (Hang et al., 2009; Pasanen et al., 
2010; Gang et al., 2011).  Recent evidence shown alternative splicing can help 
generating specific genes subunits that are expressed in a tissue-specific 
manner during hypoxia via the HIF-1 pathway (Soñanez-Organis et al., 2012). It 
also has been shown low O2 conditions alter TERT splice variant patterns in 
various somatic cell types (Anderson et al., 2007). So it is possible that 
alternative splicing is utilized in hESCs in order to mediate the cell's response to 
hypoxia. 
4.1.1Experimental limitations and future directions 
To build on the data we have presented here, numerous experimental 
extensions can be envisioned.  Based on the contrasting data in relation to the 
hypoxic response of hESCs, expansion of these works to include multiple stem 
cell lines would be valuable.  The known expression differences between hESC 
lines may also shed interesting light on trends of TERT and TERC expression 
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and the resultant levels of telomerase activity (Adewumi et al., 2007).  Moreover, 
these experiments can be applied to induced pluripotent stem cells (iPSC).  
Hypoxic response and the resultant telomerase activity can be measured across 
iPSC lines to determine differences in expression patterns between lines 
reprogrammed using different methods.  Additionally, telomerase activity can 
also be investigated during the reprogramming process to visualize trends in 
relation to pluripotency factor expression.  Each of these studies could be 
expanded to include investigation of TERT splice variant expression patterns to 
visualize transcriptional regulation patterns.  Moreover, MO antagonism of splice 
variant expression could be examined during the reprogramming process to 
determine if there are any resultant effects.    
It would also be valuable to further investigate transcriptional regulation of 
TERT isoforms from multiple angles.  We can leverage the utility of the MO 
technique and to knock down HIF1 expression in hESCs to see what changes 
are observed during HIF1 silencing in differing oxygen conditions.  Furthermore, 
we can also examine TERT splice variant expression patterns as a result of HIF 
antagonism.  Alternatively, MO mediated knockdown of c-myc could be utilized to 
observe changes that result in expression of TERT splice variants.  Over-
expression of specific TERT splice variants could also be used to determine 
whether the isoforms confer greater resistance to spontaneous differentiation and 
increase proliferation in hESCs.   
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Based on our data, the most logical extension of this work involves 
investigation of splice variant patterns during differentiation.  MOs could be 
utilized at multiple stages of hESC differentiation, using spontaneous or directed 
differentiation protocols, to assay changes in the resultant lineages.  As hypoxia 
is already known to promote differentiation into certain lineages (Prado-Lopez et 
al., 2010), combination of these experiments with different oxygen gradients 
could provide valuable supplemental information on hESC phenotypic changes.   
In conclusion, here we have demonstrated the link between changes in 
microenvironmental oxygen concentrations and the subsequent effects on extra-
telomeric role(s) of telomerase reverse transcriptase (TERT) subunit of 
telomerase.  Additionally, we have presented the novel roles of specific TERT 
splice isoforms in the regulation of hESC self-renewal and differentiation.  
Together these data provide valuable insight into the microenvironmental control 
of hESC state as well as highlight the potential extra-telomeric roles for TERT 
isoforms within hESCs.  Future investigation of the connection between TERT 
isoforms, oxygen environments, and transcriptional regulation by factors such as 
HIF will support the generation of a model for coupled extracellular intracellular 
regulation of telomerase. 
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